Takeda submits approval request for Novavax's COVID-19 vaccine in Japan

  • English
  • 日本語
  • 简体字
  • 繁體字
  • Français
  • Español
  • العربية
  • Русский

FILE PHOTO: Vials labelled "VACCINE Coronavirus COVID-19" and a syringe are seen in front of a displayed Novavax logo in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration
FILE PHOTO: Vials labelled "VACCINE Coronavirus COVID-19" and a syringe are seen in front of a displayed Novavax logo in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) - Takeda Pharmaceutical Co Ltd has submitted an approval request for Novavax's COVID-19 vaccine to Japan's health ministry, the U.S. drugmaker said late on Wednesday.

(Reporting by Shivam Patel in Bengaluru; Editing by Sriraj Kalluvila)

(c) Copyright Thomson Reuters 2021. Click For Restrictions -
https://agency.reuters.com/en/copyright.html

Reuters Japan Health United States Asia Europe US